Q&A with Molecule Group CEO Michael Kraftman, and CFO Keith Butcher

Vox Markets1 hour ago13:06

Zak Mir talks to Michael Kraftman, CEO, and Keith Butcher, CFO, of Molecule Group, as they explain the recent name change from Vulcan Two. Also discussed are the roll up strategy of the regulated UK ePharmacy and interim results.

Trading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.

Q&A with Molecule Group CEO Michael Kraftman, and CFO Keith Butcher | PiQ Markets